The increasing interest in peptides has led a large grey market, presenting substantial risks to consumers. Such materials are frequently manufactured beyond rigorous governmental oversight, implying the composition and strength can be very variable. Furthermore, these vendors may omit accurate data regarding components, possible adverse reactions,